NCT01913288

Brief Summary

The purpose of this RCT is to learn more about how sounds that we experience in the womb can affect early development in premature infants. The investigators are specifically interested determining whether and what types of maternal sensory stimulation can influence physical growth, brain maturation, respiratory stability and early vocalization during postnatal development. The investigators hypothesize that daily exposure to biological maternal sounds, such as mother's voice and heartbeat, will improve both short-term and long-term developmental in premature infants and will increase their potential to grow into healthy children.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

May 16, 2013

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 1, 2013

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

August 1, 2013

Status Verified

July 1, 2013

Enrollment Period

5.6 years

First QC Date

May 16, 2013

Last Update Submit

July 31, 2013

Conditions

Keywords

neonatal care, preterm, maternal sounds, auditory stimulation

Outcome Measures

Primary Outcomes (2)

  • Brain volume (DM^3)

    Data will be obtained by an MRI brain scan and will be calculated separately for white matter, grey matter, CSF.

    Between 36-40 weeks gestation

  • Language and cognitive skills

    Data will be obtained using the MacArthur-Bates Communicative Development Inventories (CDI), the Receptive-Expressive Emergent Language Test Third Edition (REEL-3), and the Bayley Scales of Infant Development Third Edition (Bayley-III).

    At 12 and 24 months corrected-age

Secondary Outcomes (4)

  • Oxygen saturation levels (mg/l)

    participants will be followed for the duration of hospital stay, an expected average of 6 weeks

  • Heart rate (BPM)

    participants will be followed for the duration of hospital stay, an expected average of 6 weeks

  • Infant vocalization (word count)

    Between 32-36 weeks gesation

  • Weight gain (gr/kg/day)

    participants will be followed for the duration of hospital stay, an expected average of 6 weeks

Study Arms (2)

Biological Maternal Sounds

EXPERIMENTAL

Daily Exposure to recorded mother's voice and heartbeat sounds via audio systems installed at the bedside

Other: Biological Maternal Sounds

Hospital Sounds

SHAM COMPARATOR

Exposure to standard hospital sounds; routine care.

Other: Biological Maternal Sounds

Interventions

Biological Maternal SoundsHospital Sounds

Eligibility Criteria

Age24 Weeks - 34 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Born between 24-36 weeks GA.

You may not qualify if:

  • Chromosomal or congenital anomalies; congenital infections; \> grade II IVH;
  • maternal use of tobacco, alcohol, or illicit drugs;
  • significant abuse or malnutrition during pregnancy,
  • failed ABR.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

RECRUITING

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Amir Lahav, ScD

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amir Lahav, ScD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Instructor in Pediatrics

Study Record Dates

First Submitted

May 16, 2013

First Posted

August 1, 2013

Study Start

May 1, 2013

Primary Completion

December 1, 2018

Study Completion

December 1, 2019

Last Updated

August 1, 2013

Record last verified: 2013-07

Locations